SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Katherine Payne · Study

Home/Author

Katherine Payne

13 works· latest 2020· 2 institutionscluster: provisionalORCID 0000-0002-3938-4350

h-index13

i1013

Citations1,456

Works here13

07

08

12

13

14

17

18

20

Most cited in this library

The Role of Qualitative Research Methods in Discrete Choice Experiments2017 · 171 citations
Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group2012 · 161 citations
Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis2008 · 135 citations
VALUING THE ECONOMIC BENEFITS OF COMPLEX INTERVENTIONS: WHEN MAXIMISING HEALTH IS NOT SUFFICIENT2012 · 132 citations
Cost-effectiveness analyses of genetic and genomic diagnostic tests2018 · 127 citations

Works

13 shown

Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group

Value in Health·2020·14 authors·Open access

111citations

Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome Scale

European Journal of Medical Genetics·2018·5 authors·Open access

78citations

Cost-effectiveness analyses of genetic and genomic diagnostic tests

Nature Reviews Genetics·2018·4 authors·review·Open access

127citations

The economic case for precision medicine

Expert Review of Precision Medicine and Drug Development·2018·3 authors·Open access

93citations

The Role of Qualitative Research Methods in Discrete Choice Experiments

Medical Decision Making·2017·3 authors·review·Open access

171citations

Concepts of ‘Personalization’ in Personalized Medicine: Implications for Economic Evaluation

PharmacoEconomics·2014·9 authors·Open access

96citations

Risk as an Attribute in Discrete Choice Experiments: A Systematic Review of the Literature

Patient·2014·6 authors·review

101citations

Current Methodological Issues in the Economic Assessment of Personalized Medicine

Value in Health·2013·3 authors·Open access

93citations

Making Every Contact Count: an evaluation

Public Health·2013·4 authors·Open access

59citations

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

Value in Health·2012·13 authors·Open access

161citations

VALUING THE ECONOMIC BENEFITS OF COMPLEX INTERVENTIONS: WHEN MAXIMISING HEALTH IS NOT SUFFICIENT

Health Economics·2012·3 authors

132citations

Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis

Genetics in Medicine·2008·3 authors·review·Open access

135citations

Outcome Measurement in Clinical Genetics Services: A Systematic Review of Validated Measures

Value in Health·2007·6 authors·review·Open access

99citations